Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections?

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 6, 2011, Pages 1396-1404

  McNulty, Cliodna A M ^a   Lasseter, Gemma M ^a   Charlett, André ^b   Lovering, Andy ^c   Howell Jones, Rebecca ^b   MacGowan, Alasdair ^c   Thomas, Mike ^d  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c SOUTHMEAD HOSPITAL   (United Kingdom)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antibiotic resistance; Antibiotic use; General practice; Microbiology; Questionnaire

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; NITROFURANTOIN; QUINOLONE DERIVATIVE; TRIMETHOPRIM;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; COMMUNITY; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG EFFICACY; DRUG URINE LEVEL; ESCHERICHIA COLI; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; INFECTION; INTERVENTION STUDY; LABORATORY TEST; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; PHYSICIAN; PRESCRIPTION; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUESTIONNAIRE; URINALYSIS; URINARY TRACT INFECTION;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CEPHALEXIN; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HEALTH SERVICES RESEARCH; HUMANS; MICROBIAL SENSITIVITY TESTS; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; URINARY TRACT INFECTIONS;

EID: 79956016283     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr088     Document Type: Article

References (27)

1. Livermore DL, Woodford N. Guidance to diagnostic laboratories: laboratory detection and reporting of bacteria with extended-spectrumβ-lactamases. Health Protection Agency 2004. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1194947314416 (27 January 2011, date last accessed).
2. Magee JT, Pritchard EL, Fitzgerald KA et al. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study 1996-8. BMJ 1999; 319: 1239-40.
3. Donnan PT, Wei L, Steinke DT et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. BMJ 2004; 328: 1297.
4. Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of β-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 1998; 279: 365-70.
5. van de Sande-Bruinsma N, Grundmann H, Verloo D et al. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30.
6. Department of Health. Antimicrobial Resistance: Up Against the Ropes. In CMO Annual Report 2008, London: 41-7. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/AnnualReports/DH_096206 (27 January 2011, date last accessed).
7. The Council of the European Union. Council Conclusions on Antimicrobial Resistance (AMR). 2008. http://www.consilium.europa.eu/uedocs/cms_Data/docs/pressdata/en/lsa/101035.pdf (27 January 2011, date last accessed).
8. World Health Organization Report on Infectious Diseases. Overcoming Antimicrobial Resistance World Health Organization Annual Report 2000. http://www.who.int/infectious-disease-report/2000 (27 January 2011, date last accessed).
9. Finch RG, Metlay JP, Davey PG et al. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis 2004; 4: 44-53.
10. Department of Health. Antibiotic Awareness Campaign for 2008. http://www.dh.gov.uk/en/Publichealth/Patientsafety/Antibioticresistance/DH_082512 (27 January 2011, date last accessed).
11. European Centre for Disease Prevention and Control. European Antibiotic Awareness Day, 18 November 2009. http://ecdc.europa.eu/en/eaad/Pages/Home.aspx (27 January 2011, date last accessed).
12. Sabuncu E, David J, Bernede-Bauduin C et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med 2009; 6: e1000084.
13. Bauraind I, Lopez-Lozano J-M, Beyaert A et al. Association between antibiotic sales and public campaigns for their appropriate use. JAMA 2004; 292: 2468-70.
14. Goossens H, Guillemot D, Ferech M et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006; 62: 373-9.
15. Oxman AD, Thomson MA, David DA et al. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995; 153: 1423-31.
16. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005; issue 4: CD003539. doi:10.1002/1465185.cd003539.PUB2. http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD003539/pdf_fs.html (27 January 2011, date last accessed).
17. McNulty CAM, Bowen J, Clark G et al. How should general practitioners investigate suspected urinary tract infection? Geographical variation in laboratory-confirmed bacteriuria in South West England. Commun Dis Public Health 2004; 7: 220-6.
18. Tan TY, McNulty CAM. A survey of public health laboratory protocols for antibiotic susceptibility reporting of urinary isolates submitted from general practice. Commun Dis Public Health 2002; 5: 33-7.
19. Health Protection Agency. Investigation of Urine. Standard Operating Procedure, 41 (Version 2005). http://www.hpa-standardmethods.org.uk/documents/bsop/pdf/bsop41.pdf (27 January 2011, date last accessed).
20. NHS Connecting for Health Website. Value Added Products/Services: MIQUEST. http://www.connectingforhealth.nhs.uk/systemsandservices/ssd/prodserv/vaprodmiquest (27 January 2011, date last accessed).
21. Tan TY, McNulty C, Charlett A et al. Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice. J Antimicrob Chemother 2003; 51: 379-84.
22. McNulty CAM, Smith GE, Graham C et al. PHLS primary care consultation-infectious disease and primary care research and service development priorities. Commun Dis Public Health 2001; 4: 18-26.
23. Cunney R, Aziz HA, Schubert D et al. Interpretative reporting and selective antimicrobial susceptibility release in non-critical microbiology results. J Antimicrob Chemother 2000; 45: 705-8.
24. MacKenzie FM, Gould IM, Bruce J et al. The role of microbiology and pharmacy departments in the stewardship of antibiotic prescribing in European hospitals. J Hosp Infect 2007; 65 Suppl 2: 73-81.
25. Steffee CH, Robert M, Wasilauskas M et al. Clinical use of rifampicin during routine reporting of rifampicin susceptibilities: a lesson in selective reporting of antimicrobial susceptibility data. J Antimicrob Chemother 1997; 40: 595-8.
26. Howell-Jones RS, Baker IB, McNulty CA et al. Microbial investigation of venous leg ulcers. J Wound Care 2008; 17: 353-8.
27. Health Protection Agency website guidance on diagnosis, management and treatment of infectious diseases. http://www.hpa.org.uk/infections/topics_az/primary_care_guidance/menu.htm (27 January 2011, date last accessed).